Park Ha Biological Technology Co., Ltd. (BYAH)

Every figure this model derived for BYAH, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-10-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 88,825 PaymentsToAcquireProductiveAssets 2025-10-31
cash 3,787,678 CashAndCashEquivalentsAtCarryingValue 2025-10-31
current assets 5,501,962 AssetsCurrent 2025-10-31
current liabilities 1,881,846 LiabilitiesCurrent 2025-10-31
equity 3,994,855 StockholdersEquity 2025-10-31
interest expense 41 InterestExpenseNonoperating 2025-10-31
ocf 85,852 NetCashProvidedByUsedInOperatingActivities 2025-10-31
revenue 2,524,843 Revenues 2025-10-31
sbc 24,070,200 ShareBasedCompensation 2025-10-31

The ratios

The figures themselves rather than their scores — what somebody looking up BYAH on one particular measure came for.

RatioValue
cash operating margin1.21
current ratio3.26
current ratio reported2.92
deferred revenue growth-40.25
dilution pct17.79
fcf margin-0.12
growth cv1.27
interest cover-588997.59
operating margin-956.45
owner earnings margin-953.45
revenue growth6.0
revenue growth per share-10.0
roic-9208.37
rule of 40-950.45
sbc pct revenue953.33

What to be careful about

What this model itself distrusts about BYAH's figures. Written by the derivation as it ran, not added afterwards.